PHARMACOGENETICS IN THE CLINICAL PRACTICE: DESIGN AND IMPLEMENTATION OF A CUSTOMIZED PHARMACOGENETICS GENOTYPING ARRAY (CLINPHARMARRAY®)

被引：0
|
作者：
Munoz, M. [1 ]
Dapia, I [2 ,3 ]
Tenorio, J. [2 ,3 ]
Arias, P. [2 ,3 ]
Zabala, R. H. [1 ]
Tong, H. Y. [1 ]
Frias, J. [1 ]
Lapunzina, P. [2 ,3 ]
Carcas, A. J. [1 ]
Borobia, A. M. [1 ,2 ]
机构：
[1] Univ Autonoma Madrid, IdiPAZ, La Paz Univ Hosp, Clin Pharmacol Dept,Sch Med, Madrid, Spain
[2] Univ Autonoma Madrid, IdiPAZ, La Paz Univ Hosp, INGEMM,Med & Mol Genet Inst, Madrid, Spain
[3] ISCIII, CIBERER, Madrid, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2016年 / 119卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CP89
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [41] Opportunities and limitations: the value of pharmacogenetics in clinical practice
    Daly, Ann K.
    Cascorbi, Ingolf
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (04) : 583 - 586
  • [42] The Clinical Pharmacogenetics Implementation Consortium: 10 Years Later
    Relling, Mary V.
    Klein, Teri E.
    Gammal, Roseann S.
    Whirl-Carrillo, Michelle
    Hoffman, James M.
    Caudle, Kelly E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) : 171 - 175
  • [43] Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics
    Quaranta, Sylvie
    Dupouey, Julien
    Colle, Romain
    Verstuyft, Celine
    THERAPIE, 2017, 72 (02): : 311 - 318
  • [44] Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update
    Johnson, J. A.
    Caudle, K. E.
    Gong, L.
    Whirl-Carrillo, M.
    Stein, C. M.
    Scott, S. A.
    Lee, M. T.
    Gage, B. F.
    Kimmel, S. E.
    Perera, M. A.
    Anderson, J. L.
    Pirmohamed, M.
    Klein, T. E.
    Limdi, N. A.
    Cavallari, L. H.
    Wadelius, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (03) : 397 - 404
  • [45] On the use of marker selection methods for the design of efficient genotyping tests in pharmacogenetics
    Sabbagh, A
    Darlu, P
    ANNALS OF HUMAN GENETICS, 2005, 69 : 772 - 772
  • [46] Is There a Role for Antidepressant and Antipsychotic Pharmacogenetics in Clinical Practice in 2014?
    Mulsant, Benoit H.
    Lenze, Eric J.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2014, 59 (02): : 59 - 61
  • [47] Pharmacogenetics in Clinical Practice: A Retrospective Analysis of Medication Prescriptions
    Schreeck, F.
    Schwab, M.
    Tremmel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S71 - S71
  • [48] Pharmacogenetics in Geriatric Medicine: Challenges and Opportunities for Clinical Practice
    Pilotto, Alberto
    Panza, Francesco
    Seripa, Davide
    CURRENT DRUG METABOLISM, 2011, 12 (07) : 621 - 634
  • [49] Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
    Caudle, Kelly E.
    Klein, Teri E.
    Hoffman, James M.
    Mueller, Daniel J.
    Whirl-Carrillo, Michelle
    Gong, Li
    McDonagh, Ellen M.
    Sangkuhl, Katrin
    Thorn, Caroline F.
    Schwab, Matthias
    Agundez, Jose A. G.
    Freimuth, Robert R.
    Huser, Vojtech
    Lee, Ming Ta Michael
    Iwuchukwu, Otito F.
    Crews, Kristine R.
    Scott, Stuart A.
    Wadelius, Mia
    Swen, Jesse J.
    Tyndale, Rachel F.
    Stein, C. Michael
    Roden, Dan
    Relling, Mary V.
    Williams, Marc S.
    Johnson, Samuel G.
    CURRENT DRUG METABOLISM, 2014, 15 (02) : 209 - 217
  • [50] Increasing relevance of pharmacogenetics of drug metabolism in clinical practice
    Pillans, PI
    INTERNAL MEDICINE JOURNAL, 2001, 31 (08) : 476 - 478
12345